A Phase 2a Study Evaluating the Multi-dose Activity of ARB-1467 in HBeAg-Positive and -Negative Virally Suppressed Subjects with Hepatitis B

Press/Media: Press / Media

Period2017 May 6

Media coverage

1

Media coverage

  • TitleA Phase 2a Study Evaluating the Multi-dose Activity of ARB-1467 in HBeAg-Positive and -Negative Virally Suppressed Subjects with Hepatitis B
    Media name/outletNational AIDS Treatment Advocacy Project
    CountryUnited States
    Date17/5/6
    URLwww.natap.org/2017/EASL/EASL_103.htm
    PersonsSangHoon Ahn